Masahiro Ishikane

InstitutionNational Center for Global Health and Medicine
AddressTokyo
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 35 Covid-19 publications, with a maximum of 5 publications in June 2020
    All Publications
    Bar chart showing 48 publications over 8 distinct years, with a maximum of 23 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Banno M, Tsujimoto Y, Ishikane M. Need for more randomized controlled trials with rigorous methodology to confirm that ivermectin is not a viable option for the treatment of coronavirus disease. Clin Infect Dis. 2021 Aug 06. PMID: 34358296.
      Citations:    Fields:    
    2. Togano T, Uemura Y, Asai Y, Hayakawa K, Matsunaga N, Terada M, Ohtsu H, Suzuki S, Toyoda A, Hara H, Sato R, Ishikane M, Kinoshita-Iwamoto N, Hangaishi A, Ohmagari N. The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Oct; 27(10):1498-1503. PMID: 34340930.
      Citations: 1     Fields:    Translation:Humans
    3. Okuhama A, Ishikane M, Hotta M, Sato L, Akiyama Y, Morioka S, Suzuki S, Tajima T, Yamamoto M, Teruya K, Izumi S, Ohmagari N. Clinical and radiological findings of silent hypoxia among COVID-19 patients. J Infect Chemother. 2021 Oct; 27(10):1536-1538. PMID: 34294527.
      Citations:    Fields:    Translation:Humans
    4. Akiyama Y, Kinoshita N, Sadamasu K, Nagashima M, Yoshida I, Kusaba Y, Suzuki T, Nagashima M, Ishikane M, Takasaki J, Yoshimura K, Ohmagari N. A Pilot Study on Viral Load in Stool Samples of Patients with COVID-19 Suffering from Diarrhea. Jpn J Infect Dis. 2022 Jan 24; 75(1):36-40. PMID: 34053956.
      Citations:    Fields:    
    5. Suzuki T, Kutsuna S, Saito S, Kawashima A, Okuhama A, Kanda K, Sato L, Inada M, Akiyama Y, Ide S, Nakamura K, Nakamoto T, Yamamoto K, Ishikane M, Kinoshita N, Morioka S, Hayakawa K, Ohmagari N. Clinical course of alopecia after COVID-19. Int J Infect Dis. 2021 06; 107:255-256. PMID: 33962081.
      Citations: 1     Fields:    
    6. Fujita M, Umeda T, Fujita N, Nishioka T, Iwamoto A, Ohmagari N, Ishikane M, Akashi H, Kokudo N. Japanese WHO Collaborating Centres (WHO CCs) fight against COVID-19. Glob Health Med. 2021 Apr 30; 3(2):115-118. PMID: 33937576.
      Citations:    
    7. Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N. Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies. J Infect Chemother. 2021 Jul; 27(7):1063-1067. PMID: 33962861.
      Citations: 1     Fields:    Translation:Humans
    8. Yamada G, Hayakawa K, Asai Y, Matsunaga N, Ohtsu H, Hojo M, Hashimoto M, Kobayashi K, Sasaki R, Okamoto T, Yanagawa Y, Katagiri D, Terada M, Suzuki M, Sato L, Miyazato Y, Ishikane M, Morioka S, Saito S, Ohmagari N. External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Jul; 27(7):1043-1050. PMID: 33865699.
      Citations:    Fields:    Translation:Humans
    9. Miyazato Y, Ishikane M, Inada M, Ohmagari N. Acute portal vein thrombosis with COVID-19 and cirrhosis. IDCases. 2021; 24:e01094. PMID: 33816118.
      Citations: 1     
    10. Ide S, Hayakawa K, Yamamoto K, Tsuzuki S, Tanuma J, Ohara K, Yamada G, Okuhama A, Kanda K, Suzuki T, Akiyama Y, Miyazato Y, Nakamura K, Nomoto H, Nakamoto T, Ujiie M, Saito S, Morioka S, Ishikane M, Kinoshita N, Kutsuna S, Tanaka K, Ohmagari N. Positive Ratio of Polymerase Chain Reaction (PCR) and Validity of Pre-Screening Criteria at an Outpatient Screening Center during the Early Phase of the COVID-19 Epidemic in Japan. Jpn J Infect Dis. 2021 Sep 22; 74(5):481-486. PMID: 33642432.
      Citations:    Fields:    Translation:HumansPHPublic Health
    11. Sakamoto H, Ishikane M, Ghaznavi C, Ueda P. Assessment of Suicide in Japan During the COVID-19 Pandemic vs Previous Years. JAMA Netw Open. 2021 02 01; 4(2):e2037378. PMID: 33528554.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    12. Morishita K, Takase K, Ishikane M, Otomo Y. Impact of incentives for health-care workers wearing personal protective equipment while dealing with coronavirus disease in Japan. J Occup Health. 2021 Jan; 63(1):e12213. PMID: 33788328.
      Citations: 2     Fields:    Translation:HumansCells
    13. Katagiri D, Ishikane M, Asai Y, Izumi S, Takasaki J, Katsuoka H, Kondo I, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y, Miyazato Y, Suzuki T, Kinoshita N, Ogawa T, Togano T, Suzuki M, Hashimoto M, Sakamoto K, Kusaba Y, Katsuno T, Fukaya T, Hojo M, Sugiyama M, Mizokami M, Okamoto T, Kimura A, Noiri E, Ohmagari N, Hinoshita F, Sugiyama H. Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19. J Clin Apher. 2021 Jun; 36(3):313-321. PMID: 33325084.
      Citations: 7     Fields:    Translation:Humans
    14. Hayama H, Ishikane M, Sato R, Kanda K, Kinoshita N, Izumi S, Ohmagari N, Hiroi Y. Association of plain computed tomography-determined pulmonary artery-to-aorta ratio with clinical severity of coronavirus disease 2019. Pulm Circ. 2020 Oct-Dec; 10(4):2045894020969492. PMID: 33282198.
      Citations:    
    15. Akiyama Y, Morioka S, Wakimoto Y, Kawashima A, Kanda K, Okuhama A, Suzuki T, Miyazato Y, Nomoto H, Ide S, Nakamoto T, Nakamura K, Ota M, Moriyama Y, Takaya S, Yamada K, Taguchi M, Sugito E, Izuka S, Ishiguro K, Kobayashi T, Miyake W, Kubota S, Ishikane M, Kinoshita N, Yamamoto K, Ujiie M, Kutsuna S, Hayakawa K, Saito S, Ohmagari N. Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan. Intern Med. 2020 Dec 15; 59(24):3131-3133. PMID: 33132334.
      Citations:    Fields:    Translation:HumansPHPublic Health
    16. Nakamoto T, Ishikane M, Sasaki R, Ohmagari N. Periungual desquamation in a Japanese Adult recovering from severe COVID-19. Int J Infect Dis. 2021 Jan; 102:37-39. PMID: 33075533.
      Citations:    Fields:    Translation:Humans
    17. Nakamura K, Morioka S, Kutsuna S, Iida S, Suzuki T, Kinoshita N, Suzuki T, Sugiki Y, Okuhama A, Kanda K, Wakimoto Y, Ujiie M, Yamamoto K, Ishikane M, Moriyama Y, Ota M, Nakamoto T, Ide S, Nomoto H, Akiyama Y, Miyazato Y, Hayakawa K, Saito S, Ohmagari N. Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity. Infect Prev Pract. 2020 Dec; 2(4):100098. PMID: 34316568.
      Citations: 1     
    18. Sugiyama M, Kinoshita N, Ide S, Nomoto H, Nakamoto T, Saito S, Ishikane M, Kutsuna S, Hayakawa K, Hashimoto M, Suzuki M, Izumi S, Hojo M, Tsuchiya K, Gatanaga H, Takasaki J, Usami M, Kano T, Yanai H, Nishida N, Kanto T, Sugiyama H, Ohmagari N, Mizokami M. Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. Gene. 2021 Jan 15; 766:145145. PMID: 32941953.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    19. Suzuki T, Hayakawa K, Ainai A, Iwata-Yoshikawa N, Sano K, Nagata N, Suzuki T, Wakimoto Y, Akiyama Y, Miyazato Y, Nakamura K, Ide S, Nomoto H, Nakamoto T, Ota M, Moriyama Y, Sugiki Y, Saito S, Morioka S, Ishikane M, Kinoshita N, Kutsuna S, Ohmagari N. Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers. J Infect Chemother. 2021 Jan; 27(1):120-122. PMID: 32988731.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    20. Minamimoto R, Hotta M, Ishikane M, Inagaki T. FDG-PET/CT images of COVID-19: a comprehensive review. Glob Health Med. 2020 Aug 31; 2(4):221-226. PMID: 33330811.
      Citations: 6     
    21. Oda R, Inagaki T, Ishikane M, Hotta M, Shimomura A, Sato M, Nakamoto T, Akiyama Y, Yamamoto K, Minamimoto R, Kaneko H, Ohmagari N. Case of adult large vessel vasculitis after SARS-CoV-2 infection. Ann Rheum Dis. 2020 Aug 11. PMID: 32788398.
      Citations: 9     Fields:    
    22. Katagiri D, Ishikane M, Asai Y, Kinoshita N, Ota M, Moriyama Y, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y, Miyazato Y, Suzuki T, Okuhama A, Kanda K, Wakimoto Y, Morioka S, Saito S, Yamamoto K, Ujiie M, Hayakawa K, Kustuna S, Yanagawa Y, Terada J, Takasaki J, Izumi S, Hojo M, Hinoshita F, Sugiyama M, Noiri E, Mizokami M, Ohmagari N, Sugiyama H. Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers. Crit Care Explor. 2020 Aug; 2(8):e0170. PMID: 32766565.
      Citations: 4     
    23. Okuhama A, Ishikane M, Katagiri D, Kanda K, Nakamoto T, Kinoshita N, Nunose N, Fukaya T, Kondo I, Katano H, Suzuki T, Ohmagari N, Hinoshita F. Detection of SARS-CoV-2 in Hemodialysis Effluent of Patient with COVID-19 Pneumonia, Japan. Emerg Infect Dis. 2020 Nov; 26(11):2758-2761. PMID: 32730734.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    24. Katsuno T, Suzuki M, Ishikane M, Kinoshita N, Tsukada A, Morita C, Kusaba Y, Sakamoto K, Yamaguchi Y, Tsujimoto Y, Hashimoto M, Terada J, Takasaki J, Izumi S, Okuhama A, Ide S, Moriyama Y, Matsuda K, Takamatsu Y, Mitsuya H, Hojo M, Sugiyama H. A familial cluster of severe coronavirus disease 2019 that required intubation of all family members. Infect Dis (Lond). 2020 10; 52(10):755-758. PMID: 32615051.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    25. Nakamura K, Ide S, Saito S, Kinoshita N, Kutsuna S, Moriyama Y, Suzuki T, Ota M, Nomoto H, Mizoue T, Hojo M, Takasaki J, Asai Y, Terada M, Akiyama Y, Miyazato Y, Nakamoto T, Wakimoto Y, Ujiie M, Yamamoto K, Ishikane M, Morioka S, Hayakawa K, Sugiyama H, Ohmagari N. COVID-19 can suddenly become severe: a case series from Tokyo, Japan. Glob Health Med. 2020 Jun 30; 2(3):174-177. PMID: 33330803.
      Citations: 1     
    26. Sato R, Ishikane M, Kinoshita N, Suzuki T, Nakamoto T, Hayakawa K, Bekki N, Hara H, Ohmagari N. A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan. Glob Health Med. 2020 Jun 30; 2(3):190-192. PMID: 33330806.
      Citations: 2     
    27. Citations: 4     
    28. Katagiri D, Ishikane M, Ogawa T, Kinoshita N, Katano H, Suzuki T, Fukaya T, Hinoshita F, Ohmagari N. Continuous Renal Replacement Therapy for a Patient with Severe COVID-19. Blood Purif. 2021; 50(1):129-131. PMID: 32526746.
      Citations: 6     Fields:    Translation:Humans
    29. Nomoto H, Ishikane M, Katagiri D, Kinoshita N, Nagashima M, Sadamasu K, Yoshimura K, Ohmagari N. Cautious handling of urine from moderate to severe COVID-19 patients. Am J Infect Control. 2020 08; 48(8):969-971. PMID: 32502614.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    30. Ishikane M, Miyazato Y, Kustuna S, Suzuki T, Ide S, Nakamura K, Morioka S, Katano H, Suzuki T, Ohmagari N. A Case of COVID-19 Patient with False-Negative for SARS-CoV-2 of Pharyngeal Swab, from a Chinese Traveller Returning from Wuhan, Hubei Province, China, January 2020. Jpn J Infect Dis. 2020 Nov 24; 73(6):462-464. PMID: 32475881.
      Citations:    Fields:    Translation:Humans
    31. Sakamoto H, Ishikane M, Ueda P. Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan. JAMA. 2020 May 19; 323(19):1969-1971. PMID: 32275293.
      Citations: 76     Fields:    Translation:HumansCellsPHPublic Health
    32. Suzuki T, Kutsuna S, Nakamura K, Ide S, Moriyama Y, Saito S, Morioka S, Ishikane M, Kinoshita N, Hayakawa K, Ohmagari N. Difficulty of downscaling the precautions for coronavirus disease-19 based on negative throat polymerase chain results in the early phase of infection. J Infect Chemother. 2020 Aug; 26(8):851-853. PMID: 32423700.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    33. Hayakawa K, Kutsuna S, Kawamata T, Sugiki Y, Nonaka C, Tanaka K, Shoji M, Nagai M, Tezuka S, Shinya K, Saito H, Harada T, Moriya N, Tsuboi M, Norizuki M, Sugiura Y, Osanai Y, Sugiyama M, Okuhama A, Kanda K, Wakimoto Y, Ujiie M, Morioka S, Yamamoto K, Kinoshita N, Ishikane M, Saito S, Moriyama Y, Ota M, Nakamura K, Nakamoto T, Ide S, Nomoto H, Akiyama Y, Suzuki T, Miyazato Y, Gu Y, Matsunaga N, Tsuzuki S, Fujitomo Y, Kusama Y, Shichino H, Kaneshige M, Yamanaka J, Saito M, Hojo M, Hashimoto M, Izumi S, Takasaki J, Suzuki M, Sakamoto K, Hiroi Y, Emoto S, Tokuhara M, Kobayashi T, Tomiyama K, Nakamura F, Ohmagari N, Sugiyama H. SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine. Glob Health Med. 2020 Apr 30; 2(2):107-111. PMID: 33330786.
      Citations: 5     
    34. Morioka S, Saito S, Hayakawa K, Takasaki J, Suzuki T, Ide S, Nakamura K, Moriyama Y, Akiyama Y, Miyazato Y, Nomoto H, Nakamoto T, Ota M, Sakamoto K, Katsuno T, Kusaba Y, Ishikane M, Kinoshita N, Yamamoto K, Ujiie M, Kutsuna S, Hashimoto M, Suzuki M, Izumi S, Katagiri D, Hojo M, Ohmagari N. Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 07; 289:113040. PMID: 32387791.
      Citations: 2     Fields:    
    35. Morioka S, Saito S, Hayakawa K, Takasaki J, Suzuki T, Ide S, Nakamura K, Moriyama Y, Akiyama Y, Miyazato Y, Nomoto H, Nakamoto T, Ota M, Sakamoto K, Katsuno T, Kusaba Y, Ishikane M, Kinoshita N, Yamamoto K, Ujiie M, Kutsuna S, Hashimoto M, Suzuki M, Izumi S, Katagiri D, Hojo M, Ohmagari N. Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 Apr 29; 289:113040. PMID: 33242806.
      Citations:    Fields:    
    36. Ishikane M, Kato H, Kawabata K, Ito H, Kanayama A, Matsui T, Oishi K. [The Cutting-edge of Medicine; A recent trend of emerging infections: MERS and Avian influenza A (H7N9)]. Nihon Naika Gakkai Zasshi. 2015 Jan 10; 104(1):114-9. PMID: 26571785.
      Citations:    Fields:    Translation:HumansAnimalsCells
    Ishikane's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (127)
    Explore
    _
    Co-Authors (206)
    Explore
    _
    Similar People (60)
    Explore
    _